Načítá se...
Development and Validation of a Nomogram Prognostic Model for Small-Cell Lung Cancer Patients
BACKGROUND: Small-cell lung cancer (SCLC) accounts for almost 15% of lung cancer cases in the United States. Nomogram prognostic models could greatly facilitate risk stratification and treatment planning, as well as more refined enrollment criteria for clinical trials. We developed and validated a n...
Uloženo v:
| Vydáno v: | J Thorac Oncol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7678404/ https://ncbi.nlm.nih.gov/pubmed/29902534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2018.05.037 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|